Hyperglycaemia and hypertension have been reported to occur more commonly in individuals with MRAP2 mutations than in those with MC4R mutations, which led to the suggestion that MRAP2 variants may affect signaling by other GPCRs (6). This evidence concerns the gene MRAP2 and Hyperglycemia.